References
- Kalajian AH, Waldman M, Knable AL. Nodular primary localized cutaneous amyloidosis after trauma: a case report and discussion of the rate of progression to systemic amyloidosis. J Am Acad Dermatol 2007;57:S26–S29.
- Westermark P, Murphy C, Eulitz M, Wallgren-Pettersson C, Udd B, Hellman U, Ihse E, Weiss D, Solomon A. Galectin 7-associated cutaneous amyloidosis. Amyloid 2010;127:71.
- Schröder R, Deckert M, Linke RP. Novel isolated cerebral AL[lambda] amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy. J Neuropathol Exp Neurol 2009;68:286–299.
- Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis. Review and long-term follow-up of 16 cases. Arch Dermatol 2003;139:1157–1159.
- Fuenzalida H, Valenzuela F, Misad C. Nodular amyloidosis: two clinical case reports. Clin Exp Dermatol 2008;34:93–94.
- Lai KW, Lambert E, Coleman S, Scott G, Mercurio MG. Nodular amyloidosis: differentiation from colloid milium by electron microscopy. Am J Dermatopathol 2009;31:472–474.
- Love WE, Miedler JD, Smith MK, Mostow EN, Cooper KD, Gilliam AC. The spectrum of primary cutaneous nodular amyloidosis: two illustrative cases. J Am Acad Dermatol 2008;58:S33–S35.
- Hussein MA, Juturi JV, Rybicki L, Lutton S, Murphy BR, Karam MA. Etanercept therapy in patients with advanced primary amyloidosis. Med Oncol 2003;20:283–290.
- Abraham RS, Geyer SM, Price-Troska TL, Allmer C, Kyle RA, Gertz MA, Fonseca R. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood 2003;101:3801–3808.
- Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G. Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment. Blood 2002;100:948–953.
- Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583–596.
- Brownstein MH, Helwig EB. The cutaneous amyloidoses, I: localized forms. Arch Dermatol 1970;102:8–19.
- Woollons A, Black MM. Nodular localized primary cutaneous amyloidosis. A long-term follow-up study. Br J Dermatol 2001;145:105–109.
- Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, Perfetti V, Leijsma MK, Bootsma H, Hazenberg BP. Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum 2008;58:1992–1999.
- Koh M, Kwok CYK, Tan HW, Mancer JFK. A rare case of primary cutaneous nodular amyloidosis of the face. J Eur Acad Dermatol 2008;22:1011–1012.
- Bozikov K, Janezic T. Excision and split thickness skin grafting in the treatment of nodular primary localized cutaneous amyloidosis. Eur J Dermatol 2006;16:315–316.
- Feito-Rodriguez M, Garcia-Macarron J, Pagan-Munoz B, Marino-Enriquez A, Vidaurrazaga-Diaz y Acraya C, Diaz-Diaz RM, Casado-Jimenez M. Disseminated nodular primary localized cutaneous amyloidosis. Actas Dermosifiliogr 2008;99:648–652.
- Hughes M, Doig A, Soutar R Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns. Br J Haematol 2007; 137:486–487.